Wed | Jan 23, 2019

Bayer divulges research findings on Qlaira contraceptive

Published:Saturday | July 14, 2018 | 12:00 AM
From left: Consultant obstetrician and gynaecologist Dr Milton Hardie; Product Manager, Short Acting Contraception Franchise, Bayer, Mairyn Araya; and Guatemala-based obstetrician and gynaecologist practitioner Dr Abner Santos exchange pleasantries on Tuesday at the Knutsford Court Hotel, St Andrew, ahead of a special industry engagement for female contraceptive Qlaira. Dr Hardie chaired the event hosted by Bayer Healthcare (manufacturers of Qlaira) and LASCO Distributors Limited (a local distributor of Bayer brands), which presented research findings surrounding Qlaira, the only United States FDA-approved contraceptive for the reduction of heavy menstrual bleeding, to an audience of local medical practitioners and pharmacists.